Ambiguous genitalia |
Steroid biosynthesis |
Others or sex reversal |
CYP11A1; CYP11B1; CYP11B2; CYP17; CYP21;CYP21A2; HSD3B2; POR; SRD5A2; StAR |
AMH; AMHR2; AR; ARX; LHCGR; LHR; NRFA1;NR0B1; RSP01; SOX9; SRY; WT1 |
Gonadal dysgenesis |
CYP11A1; Dicentric Y chromosome; NR5A1(Sf1); NR0B1; SRY; SRY promoter; WT1 |
Hypospadias |
AR; ATF3; MAMLD1 (CXorf6); Dicentric Y; EFNB2; ESR1; ESR2; FGFR2; HOXA13; HOXD11; HOXD13; INSL3; MID1; RXFP2 (LGR8/GREAT) |
Micropenis |
Gene defects |
Structural chromosome defects |
Numerical chromosome defects |
ALKBH1; AHRR; ALG12; ESR1; GHR; NRSA1; SOX2; TBX3 |
Chromosomes 2, 4, 5, 6, 7, 8, 11, 12,14, 15, 16, 17, 18 and 21 |
Ring X, Y; Trisomy 14; 49, XXXXY; 47, XYY |
Cryptorchidism |
ARX; CYP19A1; DHH; ESR1; HOXD13; INSL3; KRAS; NRSA1; PTPN11; PWCR; RAF1; RXFP2; SOS1; SOX2; SPAG4L; SPATA12; ZNF214; ZNF215 |
Testis cancer |
AR; BMP; CTNNB1; DIABLO; DND1; EGFR; EEF1A; FOXL2; GNAS; HMGA1; HMGA2; KIT; KND1; KRAS; NANOG; PATZ1; POLG; POU5F1; REG1; SMAD1; SMAD5; SOX2; SOX17; SPATA12. TSPY1; WT1 |
Vas deferens |
CFTR, HNF1B |